Naiara Perurena

6PUBLICATIONS
61CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 09, 2024
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution.

Amy E Schade, Naiara Perurena, Yoona Yang

|Aug 09, 2024
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers.

Patrick Loi, Amy E Schade, Carrie L Rodriguez

|Apr 16, 2024
Combinatorial strategies to target RAS-driven cancers.

Naiara Perurena, Lisa Situ, Karen Cichowski

|Feb 22, 2022
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.

Borja Ruiz-Fernández de Córdoba, Haritz Moreno, Karmele Valencia

Pageof 1